SHSE:688050 (China)
Â
Class A
Â¥
90.01
(-0.66%)
Dec 26
Business Description
Eyebright Medical Technology (Beijing) Co Ltd
ISIN : CNE1000041J5
Share Class Description:
SHSE:688050: Class ACompare
Compare
Traded in other countries / regions
688050.China IPO Date
2020-07-29Description
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.78 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 1.38 | |||||
| Interest Coverage | 21.18 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 13.53 | |||||
| Beneish M-Score | -1.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 43.4 | |||||
| 3-Year EBITDA Growth Rate | 36.6 | |||||
| 3-Year EPS without NRI Growth Rate | 39.9 | |||||
| 3-Year Book Growth Rate | 11.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 32.06 | |||||
| Future 3-5Y Total Revenue Growth Rate | 37.51 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.83 | |||||
| 9-Day RSI | 46.02 | |||||
| 14-Day RSI | 46.81 | |||||
| 6-1 Month Momentum % | 18.66 | |||||
| 12-1 Month Momentum % | -9.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.76 | |||||
| Quick Ratio | 3.76 | |||||
| Cash Ratio | 1.9 | |||||
| Days Inventory | 160.56 | |||||
| Days Sales Outstanding | 76.64 | |||||
| Days Payable | 40.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.53 | |||||
| Dividend Payout Ratio | 0.24 | |||||
| Forward Dividend Yield % | 0.53 | |||||
| 5-Year Yield-on-Cost % | 0.53 | |||||
| Shareholder Yield % | -1.49 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.65 | |||||
| Operating Margin % | 32.1 | |||||
| Net Margin % | 27.21 | |||||
| FCF Margin % | -12.74 | |||||
| ROE % | 16.79 | |||||
| ROA % | 11.98 | |||||
| ROIC % | 15.4 | |||||
| ROC (Joel Greenblatt) % | 27.16 | |||||
| ROCE % | 15.42 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 46.47 | |||||
| Forward PE Ratio | 33.31 | |||||
| PE Ratio without NRI | 45.21 | |||||
| Price-to-Owner-Earnings | 103.93 | |||||
| PEG Ratio | 1.03 | |||||
| PS Ratio | 12.67 | |||||
| PB Ratio | 7.37 | |||||
| Price-to-Tangible-Book | 9 | |||||
| Price-to-Operating-Cash-Flow | 57.54 | |||||
| EV-to-EBIT | 41.3 | |||||
| EV-to-EBITDA | 41.3 | |||||
| EV-to-Revenue | 13.16 | |||||
| EV-to-FCF | -103.29 | |||||
| Price-to-Projected-FCF | 13.96 | |||||
| Price-to-Graham-Number | 4.22 | |||||
| Price-to-Net-Current-Asset-Value | 166.69 | |||||
| Earnings Yield (Greenblatt) % | 2.42 | |||||
| FCF Yield % | -1.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eyebright Medical Technology (Beijing) Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,358.345 | ||
| EPS (TTM) (Â¥) | 1.95 | ||
| Beta | 1.3 | ||
| Volatility % | 54.57 | ||
| 14-Day RSI | 46.81 | ||
| 14-Day ATR (Â¥) | 3.992582 | ||
| 20-Day SMA (Â¥) | 92.382 | ||
| 12-1 Month Momentum % | -9.08 | ||
| 52-Week Range (Â¥) | 65.17 - 118 | ||
| Shares Outstanding (Mil) | 189.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eyebright Medical Technology (Beijing) Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eyebright Medical Technology (Beijing) Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eyebright Medical Technology (Beijing) Co Ltd Frequently Asked Questions
What is Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050)'s stock price today?
The current price of SHSE:688050 is ¥90.01. The 52 week high of SHSE:688050 is ¥118.00 and 52 week low is ¥65.17.
When is next earnings date of Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050)?
The next earnings date of Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050) is .
Does Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050) pay dividends? If so, how much?
The Dividend Yield %  of Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050) is 0.53% (As of Today), Highest Dividend Payout Ratio of Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050) was 0.24. The lowest was 0.19. And the median was 0.19. The  Forward Dividend Yield % of Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050) is 0.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers